To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Name: To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.
Published: 2023
License: Public Domain

Sichuan University · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

gastric-cancer

gastric cancer, neoadjuvant therapy, cadonilimab, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Related documents